|
1
|
Bhyrapuneni G, Mudigonda K, Penta KK, Chowdary Palacharla VR, Muddana N, Jayarajan P, Abraham R, Subramanian R, Goyal VK, Pandey SK, Boggavarapu RK, Shinde AK, Nirogi R. P2‐026: SUVN‐G3031, a Potent and Selective H3 Receptor Inverse Agonist: Safety, Tolerability and Pharmacokinetics in Humans. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1230] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
2
|
Jayarajan P, Bhyrapuneni G, Mudigonda K, Penta KK, Muddana N, Chowdary Palacharla VR, Benade V, Abraham R, Subramanian R, Goyal VK, Pandey SK, Boggavarapu RK, Ajjala DR, Rasheed MA, Nirogi R. P3‐016: SUVN‐D4010, A Potent and Selective 5‐HT
4
Receptor Partial Agonist: Safety, Tolerability and Pharmacokinetics in Humans. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1673] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
|
3
|
Nirogi R, Mudigonda K, Penta KK, Bhyrapuneni G, Benade V, Muddana N, Chowdary Palacharla VR, Ajjala DR, Goyal VK, Pandey SK, Abraham R, Jayarajan P, Kambhampati R, Shinde AK. P1‐085: SUVN‐502, Potent and Pure 5‐HT
6
Receptor Antagonist: Proof‐of‐Concept Study Design in Moderate Alzheimer’s Disease Patients. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
|
4
|
Nirogi R, Mudigonda K, Penta KK, Bhyrapuneni G, Ajjala DR, Muddana N, Chowdary Palacharla VR, Goyal VK, Pandey SK, Abraham R, Jayarajan P, Badange RK, Kambhampati R. P3‐296: Safety, tolerability, and pharmacokinetics of a potent and selective 5‐ht
6
receptor antagonist, SUVN‐502, following multiple ascending doses in healthy elderly subjects, and effect of gender and food on single‐dose pharmacokinetics. Alzheimers Dement 2015. [DOI: 10.1016/j.jalz.2015.06.1669] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
|
5
|
Nirogi R, Mudigonda K, Penta KK, Bhyrapuneni G, Ajjala DR, Muddana N, Benade VS, Palacharla RC, Goyal VK, Pandey SK, Abraham R, Jayarajan P, Badange RK, Kambhampati R. P3‐390: EFFECT OF GENDER AND FOOD ON THE SINGLE‐DOSE PHARMACOKINETICS OF SUVN‐502, A POTENT AND SELECTIVE 5‐HT6 RECEPTOR ANTAGONIST. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.1484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|